Citigroup analyst Joanne Wuensch maintains Haemonetics (NYSE:HAE) with a Neutral and raises the price target from $80 to $88.
Citigroup Maintains Neutral on Haemonetics, Raises Price Target to $88
Citigroup analyst Joanne Wuensch maintains Haemonetics (NYSE:HAE) with a Neutral and raises the price target from $80 to $88.
Related Posts
Recap: First Financial Northwest Q4 Earnings
First Financial Northwest (NASDAQ:FFNW) reported its Q4 earnings results on Thursday, January 27, 2022 at 09:15 AM.
Here's what investors need to know about the announcement.
CVR Partners Q2 Sales $138.00M Beat $90.30M Estimate
CVR Partners (NYSE:UAN) reported quarterly sales of $138.00 million which beat the analyst consensus estimate of $90.30 million by 52.82 percent. This is a 31.31 percent increase over sales of $105.09 million the same
Cathie Wood Scoops Up $19.7M In This Automation Firm As Shares Crash
Tesla Inc (NASDAQ: TSLA) bull Cathie Wood’s Ark Investment Management on Monday raised its exposure in the New York-based software automation company UiPath Inc (NYSE: